A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

NCT07688772 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: SHR-1819 Injection
DRUG: SHR-1819 Injection Placebo

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd